Hetero Drugs is an Indian pharmaceutical company and the worlds largest producer of anti-retroviral drugs. Heteros business includes APIs, generics, biosimilars, custom pharmaceutical services, and branded generics.

Production Department
Area of Work : Granulation, Compression, Coating
Post : Jr. Officer/Officer/ Jr. Executive
Qualification : B.Pharma / M.Pharma
Experience : 1 to 3 Yrs

Shodhana Laboratories  A WHO GMP ,ISO 9001-2008 and ISO 14000:2004 certified company, Shodhana Laboratories is considered to be one of the most dynamic Active Pharmaceutical Ingredients and Intermediates manufacturing companies.  Today, we have the technically most advanced production facilities and our entire manufacturing process is as per ICH & cGMP guidelines. We also have a world class R&D lab manned by a dynamic team of highly qualified and experienced scientists.

Vital Pharma is an endeavour to offer trustworthy partnership comprising superior quality products and services par excellence in Contract Manufacturing, Animal Nutrition, Human Nutrition, Aquaculture and Vitamin pre-mixes. Vital Therapeutics & Formulations is designed to meet International Regulatory requirements such as CGMP, WHO, ISO 9001 & FSSC 22000 and recognised for abiding to vigorous quality and service standards for product development, analytical services, packaging and regulatory services.

Spica Lab was established in 2001 with prime focus on enhancing and improving life with a feeling of wholesome and well-being for a better tomorrow. A key to a better life is not just feeling good physically and mentally but spiritually and socially as well.

Mount Sinai researchers have made two important discoveries about the mechanism by which bladder cancer cells foil attacks from the immune system. The research, published in Cancer Cell in September, could lead to a new therapeutic option for patients with these types of tumors.

Zika virus has a trick up its sleeve. Once inside the body, the virus likes to make a bee line for dendritic cells, the cells we rely on to launch an effective immune response.

“Dendritic cells are major cells of the innate immune system,” says LJI Professor Sujan Shresta, Ph.D., a member of the LJI Center for Infectious Disease and Vaccine Research. “How is this virus so clever that it’s able to establish infection in cells that would normally fight infections?”

Zydus Lifesciences Limited’s has received approval from the United States Food and Drug Administration (USFDA) to market Lenalidomide Capsules, USP 2.5 mg, 5 mg, 10 mg, 15 mg, 20 mg, and 25 mg. The company has received final approvals for 5 mg, 10 mg, 15 mg and 25 mg strengths and tentative approvals for 2.5 mg and 20 mg strength. USRLD: Revlimid®.

Lupin Limited announced that Health Canada has approved Rymti, its biosimilar to Enbrel (etanercept), for use in Canada.

Rymti® is indicated in the treatment of rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, axial spondyloarthritis (including ankylosing spondylitis and non-radiographic axial spondyloarthritis), plaque psoriasis and paediatric plaque psoriasis.

Under the National Health Mission, the vacant posts under the Navi Mumbai Municipal Corporation under the National Urban Health Mission are to be filled on purely contractual basis (11 months) and on contract basis as shown in the table below. 

Post : Pharmacist

Central Medical Services Society has been established with the approval of Cabinet on 24.08.2011 as a Central Procurement Agency to streamline drug procurement and distribution system of Department of Health and Family Welfare, Ministry of Health and Family Welfare, Government of India and to eliminate existing deficiencies.

The wave of globalization has propelled the expansion of Indian pharma sector. India is amongst the top 10 countries of the world, in terms of volume and value of Pharmaceutical products. Enthusiastic and entrepreneurial efforts have turned Gujarat into the hub of Pharma industry.  The innovative and translational approach of the Indian scientists resulted in paradigm shift from industrial age to knowledge enriched economy.

The Department of Public Health and Preventive Medicine is responsible for the implementation of various National and State Health Programmes.

The Himachal Pradesh National Law University (HPNLU, Shimla), was established by the State Government in the year 2016, by an Act of the Legislature (Act 16 of 2016). The University started functioning from 5th of October, 2016. The first batch of B.A.LL.B. students was inducted on the basis merit/score secured by them in different national level entrance tests. The University started its own Entrance Exam: HPNLET, in 2017-2018 and continued for academic session of 2018-2019 for admissions in various courses i. e. B.A.LL.B.; B.B.A. LL.B.; and LL.M.

University of Pittsburgh researchers describe for the first time a pathway by which cells repair damaged lysosomes, structures that contribute to longevity by recycling cellular trash. The findings are an important step towards understanding and treating age-related diseases driven by leaky lysosomes.

Cosmetic and patents are the words that are rarely used together. Promotion of cosmetics through ‘chemistry’ or ‘chemical’ is not a regular practice. Nevertheless, these terms like chemistry, cosmetics and patents often make up a successful composition that leads to the advancement of variety of beauty products. In USA, first patent was given to liquid soap in 1865 followed by patent for deodorant in 1888.

Biomedical International Conference, India will be organizing an International conference on “Intellectual Property rights and Advanced drug delivery system" from 24th Sept 2022 - 25th September 2022 (2 days) in collaboration with The Association of African Students in India-AASI. Please find enclosed herewith a soft copy of the conference flyer for your reference and kindly share it with your students, faculty, and colleagues.

Bristol Myers Squibb announced new two-year results from the POETYK PSO long-term extension (LTE) trial demonstrating clinical efficacy was maintained with continuous Sotyktu™ (deucravacitinib) treatment in adult patients with moderate-to-severe plaque psoriasis. This analysis assessed patients from the pivotal POETYK PSO-1 trial who transitioned into the LTE trial.

Targeting FGFR has recently emerged as a promising strategy in the treatment of cholangiocarcinoma (CCA), a very aggressive rare malignancy. At ESMO Congress 2022, two new agents were added to the list of FGFR inhibitors being investigated, showing some clinical benefits or potential in patients not previously treated with this anticancer drug class.

Two early studies investigate the anticancer activity of derazantinib and RLY-4008 in patients with FGFR inhibitor-naive cholangiocarcinoma.

The USFDA rejected Alvotech’s application to approve its biosimilar of AbbVie’s Humira after an inspection of the company’s Reykjavik, Iceland, manufacturing plant.

Alvotech received communication from the U.S. Food and Drug Administration (USFDA) detailing its assessment of the March 2022 inspection of Alvotech’s manufacturing facility in Reykjavik, Iceland and Alvotech’s subsequent written responses to the FDA.